Production (Stage)
enGene Holdings Inc.
ENGN
$3.33
$0.082.46%
NASDAQ
04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | -7.24% | 29.29% | 29.57% | 121.99% | 389.82% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 56.70% | 147.03% | 67.16% | 168.23% | 265.42% |
Operating Income | -56.70% | -147.03% | -67.16% | -168.23% | -265.42% |
Income Before Tax | -70.92% | -129.01% | 81.47% | -200.36% | -183.28% |
Income Tax Expenses | 1,042.86% | 160.00% | 11.76% | -- | -- |
Earnings from Continuing Operations | -72.28% | -129.82% | 81.46% | -199.75% | -183.68% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -72.28% | -129.82% | 81.46% | -199.75% | -183.68% |
EBIT | -56.70% | -147.03% | -67.16% | -168.23% | -265.42% |
EBITDA | -56.79% | -147.93% | -67.73% | -168.77% | -266.64% |
EPS Basic | -33.19% | -4.59% | 99.71% | 96.25% | 95.91% |
Normalized Basic EPS | -32.14% | -7.91% | 99.07% | 87.35% | 95.01% |
EPS Diluted | -33.19% | -4.59% | 99.71% | 96.25% | 95.91% |
Normalized Diluted EPS | -32.14% | -7.91% | 99.07% | 87.35% | 95.01% |
Average Basic Shares Outstanding | 29.35% | 119.75% | 6,168.18% | 6,198.16% | 5,579.45% |
Average Diluted Shares Outstanding | 29.35% | 119.75% | 6,168.18% | 6,198.16% | 5,579.45% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |